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+) is a free oxygen radical with
powerful vasodilator properties studied in many
tissues. It is produced by NO
+ synthases in endothe-
lial cells upon stimulation by various agents like
cytokines and tumor necrosis factor. The end-pro-
ducts of NO
+ are nitrite and nitrate. Their levels are
used biochemically to determine NO
+ synthase
activity. Evidence is accumulating for the role of
NO
+ in the pathophysiology of inflammatory Beh-
c ¸et’s disease (BD). Indeed, we first demonstrated that
serum NO
+ production is increased in active BD,
suggesting a possible new activity marker.
1 More
recently, we have reported that pro-inflammatory
cytokines, inducers of NO
+, and lipid peroxidation
are increased and associated with decreased antiox-
idant enzyme activities in BD.
2,3 Our findings were
then supported by four independent investigations,
one of which was from the present group.
47 More-
over, aqueous humor NO
+ levels were found to be
increased in uveitic BD patients.
8 Furthermore,
Salvarani et al.
9 have recently shown that the Glu-
Asp298 polymorphism of endothelial NO
+ synthase
gene is associated with BD susceptibility. Therefore,
to support our previous studies, this report further
investigated for the first time NO
+ levels in red blood
cells of BD patients compared with age-matched and
sex-matched healthy control volunteers.
A total of 20 patients with BD (16 men, four
women), with a mean age of 33.4 years, and 15
healthy control subjects (12 men, three women), with
a mean age of 32.1 years, were enrolled in this study.
Patients with BD had to fulfil the International Study
Group criteria for the diagnosis of BD.
10
Fasting whole-blood samples were taken from BD
patients and control subjects by venipuncture from
an antecubital peripheral vein into heparinised plain
tubes to prepare the erythrocyte sediment. The buffy
coat on the erythrocyte sediment was carefully
separated. The erythrocyte sediment was subse-
quently washed three times with 10-fold volumes of
0.9% sodium chloride solution to remove the plasma
remnants. Following this, the erythrocyte sediment
was treated with four-fold volumes of ice-cold
deionised water to obtain hemolysate. NO
+ is a labile
compound and has a brief half-life, and therefore its
detection as the native NO
+ molecule is difficult. It is
rapidly converted to the stable end-products nitrate
(NO3
) and nitrite (NO2
) in typical oxygenated
aqueous solutions and tissues. Thus, erythrocyte total
nitrite levels were measured as an index of NO
+
production. For total nitrite detection, lysate was
treated with copperised cadmium in glycine buffer at
pH 9.7 (2.5/3.0 g of cadmium granules for a 4 ml




surement of total nitrite was based on the Griess
reaction, in which a chromofore with a strong
absorbance at 540 nm is formed by the reaction of
nitrite with a mixture of sulphanilamide and N-(1-
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255naphthyl)-ethylenediamine. A standard curve was
established with a set of serial dilutions (10
8 to
10
3 mol/l) of sodium nitrite.
The analysis was performed by the same examiner
(M.C ¸.), who was blinded to diagnosis, and was
assayed in duplicate. Data were presented as nano-
moles per gram of hemoglobin (Hb) (mean9 /stan-
dard deviation). The Mann/Whitney U-test was used
for statistical analysis and pB/0.05 was considered
significant. BD patients had significantly (pB/0.001)
higher erythrocyte NO
+ concentrations (179.79 /33.6
nmol/g Hb) when compared with control subjects
(129.79 /23.4 nmol/g Hb). The significantly increased
NO
+ levels in erythrocytes from BD patients indi-
cated a role of NO
+ in the pathogenesis of this
unique disorder.
NO
+ is an important intercellular physiological
messenger of immunity and inflammation for the
vascular system, with the inhibition of platelet adhe-
sion.
12 It is produced by various cell types including
the endothelium to facilitate communication. The
formation of NO
+ is catalysed by NO
+ synthase, an
enzyme present in a variety of cell types including
red blood cells, which can be induced by cytokines
during inflammatory and infectious processes, result-




+ is accepted as an oxygen radical and
also recognised as a major messenger molecule
involved in the regulation of vasodilatation.
NO
+ is present in the blood at 10
7 M under
physiological conditions, but at concentrations higher
than 10
6 M during inflammatory disease states.
14
Because the erythrocyte membrane is highly perme-
able to NO
+, it is quickly scavenged by Hb in red
blood cells when NO
+ is released into the blood-
stream or oxidised to nitrite.
15 Nitrite can also enter
erythrocytes rapidly and reacts with oxyhemoglobin
but does not exert a strong oxidant stress on these
cells. Peroxynitrite anion, the reactive species formed
in vivo by the reaction of NO
+ with the superoxide
anion, is also capable of diffusing across erythrocyte
membranes via anion channels and passive diffu-
sion.
16 Moreover, recent studies have revealed that
human erythrocytes possess a NO
+ synthase. There-
fore, we think that excess NO
+ levels found in this
study may be liberated from the endothelium of
conductance and vessels in inflammatory BD, which
is then taken up by red blood cells, and/or NO
+ may




+, in turn, may cause lipid peroxidation,
cellular dysfunction and death. Indeed, we demon-
strated the presence of strong pro-oxidants (radicals)
during the course of BD, suggesting the presence of
an imbalance in the oxidant/antioxidant system in
the pathogenesis of BD.
13 In other words, because
NO
+ participates in the compensatory response to
chronic vascular injury,
14 its increased levels seem to
be pathophysiologically significant during the course
of this unique vasculitic disorder. Moreover, these
results are consistent with the hypothesis that NO
+
may have a crucial role in vasoregulatory mechan-
isms in BD patients.
1,5 Likewise, cytokine-induced
overproduction of NO
+ by immunocompetent cells
may be the other possible pathophysiological con-
sequences with subsequent development of oxida-
tive stress in BD. Therefore, the present finding
indicates NO
+-dependent alterations of oxidative
metabolic burst in such patients, and also questions
the possible participation of erythrocytes during the
course of inflammation in BD. In other words, NO
+-
Hb may serve as a store of NO
+ in red blood cells,
and oxidative stress status in the blood seems to be
deteriorated as a whole in BD, both in plasma and
erythrocytes, confirming an impaired oxidant/anti-
oxidant equilibrium.
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